Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.
Romo M, LaHood A, Mitnick CD, Rich ML, Trevisi L, Skrahina A, Oyewusi L, Bastard M, Khan PY, Huerga H, Khan U, Herrera Flores E, Atshemyan H, Hewison C, Rashitov M, Samieva N, Gómez-Restrepo C, Krisnanda A, Kotrikadze T, Siraj F, Khan AW, Ndjeka N, Adenov M, Seung KJ, Kumsa A, Franke MF. Romo M, et al. Among authors: samieva n. Clin Infect Dis. 2026 Jun 12:ciag361. doi: 10.1093/cid/ciag361. Online ahead of print. Clin Infect Dis. 2026. PMID: 42283325 Free article.
Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.
Romo M, LaHood A, Mitnick CD, Rich ML, Trevisi L, Skrahina A, Oyewusi L, Bastard M, Khan PY, Huerga H, Khan U, Flores EH, Atshemyan H, Hewison C, Rashitov M, Samieva N, Gómez-Restrepo C, Krisnanda A, Kotrikadze T, Siraj F, Khan AW, Ndjeka N, Adenov M, Seung KJ, Kumsa A, Franke MF. Romo M, et al. Among authors: samieva n. medRxiv [Preprint]. 2026 May 29:2026.03.14.26348377. doi: 10.64898/2026.03.14.26348377. medRxiv. 2026. Update in: Clin Infect Dis. 2026 Jun 12:ciag361. doi: 10.1093/cid/ciag361. PMID: 41891020 Free PMC article. Updated. Preprint.
The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.
Sinha A, Klebe R, Rekart ML, Alvarez JL, Skrahina A, Yatskevich N, Solodovnikova V, Viatushka D, Parpieva N, Safaev K, Liverko I, Tigay Z, Moe S, Khristusev A, Allamuratova S, Mirzabaev S, Achilov M, Samieva N, Lachenal N, Merle CS, Sall FB, Restrepo CG, Tan C, Sitali N, Saunders MJ. Sinha A, et al. Among authors: samieva n. Clin Infect Dis. 2025 Nov 6;81(4):838-845. doi: 10.1093/cid/ciaf035. Clin Infect Dis. 2025. PMID: 39964841 Free PMC article.
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation.
Sweeney S, Laurence YV, Berry C, Singh MP, Dodd M, Fielding K, Kazounis E, Moodliar R, Solodovnikova V, Tigay Z, Liverko I, Parpieva N, Butabekov I, Usmanova R, Rassool M, Motta I, Nyangweso GM, Jolivet P, Abdrasuliev T, Moe S, Aw PS, Samieva N, Nyang'wa BT. Sweeney S, et al. Among authors: samieva n. Lancet Glob Health. 2025 Feb;13(2):e355-e363. doi: 10.1016/S2214-109X(24)00467-4. Lancet Glob Health. 2025. PMID: 39890235 Free article.
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
Franke MF, Khan P, Hewison C, Khan U, Huerga H, Seung KJ, Rich ML, Zarli K, Samieva N, Oyewusi L, Nair P, Mudassar M, Melikyan N, Lenggogeni P, Lecca L, Kumsa A, Khan M, Islam S, Hussein K, Docteur W, Chumburidze N, Berikova E, Atshemyan H, Atwood S, Alam M, Ahmed S, Bastard M, Mitnick CD. Franke MF, et al. Among authors: samieva n. Am J Respir Crit Care Med. 2021 Jan 1;203(1):111-119. doi: 10.1164/rccm.202001-0135OC. Am J Respir Crit Care Med. 2021. PMID: 32706644 Free PMC article.